SCOT-HEART feelings
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2018 – Aug 2025Where it's discussed
-
X / Twitter43 posts
-
News36 articles
-
Facebook15 posts
-
Blogs14 articles
-
YouTube4 videos
-
Reddit2 posts
AI synopsis
What people are saying
The overall discussions express strong approval and fascination with the study's findings, as seen in phrases like 'CTA first saves lives,' and references to significant trials like SCOT-HEART. Words like 'significantly lower' and 'game changer' convey enthusiasm, while detailed mentions of the trial design and long-term benefits show a deep interest and perceived impact of the research on clinical decision-making.
Most discussions support the article's findings, with many posts emphasizing the benefits of coronary CT angiography (CTA) for reducing long-term cardiovascular events, suggesting a consensus on its positive impact.
The posts demonstrate high curiosity, referencing studies like SCOT-HEART and comparing CTA to other diagnostic methods, showing researchers and clinicians are highly engaged with the topic.
Several posts delve into detailed aspects such as the trial results, methodologies, and implications for clinical practice, indicating deep involvement with the research.
Posts highlight the potential for CTA to influence patient management strategies and improve outcomes over five years, reflecting a belief that this research could shape future guidelines and practices.
Abstract in brief
- A multicenter trial involving 4146 patients with stable chest pain found that adding coronary CT angiography (CTA) to standard care reduced the 5-year risk of death from coronary heart disease or nonfatal myocardial infarction, with the CTA group showing a lower event rate (23.48%) compared to the standard care group (39.81%).
- Although initially more invasive procedures were performed in the CTA group, overall rates of invasive coronary angiography and revascularization at 5 years were similar between groups, but the CTA group received more preventive and antianginal therapies, which may contribute to better outcomes.
- The study concluded that incorporating CTA into standard care improved 5-year cardiovascular outcomes without increasing the rates of death from any cause, suggesting that CTA can be a valuable tool in managing patients with stable chest pain.
Top posts
Most liked on X and Bluesky@CoronaryDoc @purviparwani @GreggWStone @Drroxmehran @mmamas1973 @rallamee @RonBlankstein @DavidLBrownMD @DrMarthaGulati @AChoiHeart @ToddVillinesMD @DrRyanPDaly @lesleejshaw @onco_cardiology @MBittencourtMD @ErinMichos Measure coronary outcomes with a coronary intervention = scene set for positive result, but unmeasured outcomes may be equally important. 5yr mortality was no different with CTCA strategy in SCOTHEART https://t.co/PD2Pl3aPGX https://t.co/5Be91kilwZ
6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early detection/prevention #SCOTHEART https://t.co/u25PsmjYUG @NEJM #SCCT2022 https://t.co/ucfoJmARUC
#CTAfirst saves lives? Yes, please check this report out…. https://t.co/4kYoaYutPI Do you wait to “embrace” a new approach until the evidence is created ? Or would you rather embrace your community and create the evidence together? @sbrugaletta @Ortega_Paz @TCTMD @CRT_meeting https://t.co/hXyK17bQDz
@Cardiotweets83 @Cardio_ciencias @VazyurVasquez @wikimagen @ecardioimage @iamritu @purviparwani @VLSorrellImages @JGrapsa @jpcostabel @josejgdnews @carlos_sierra @hatemsoliman SCOT Heart https://t.co/pCiYnLi9GM
@FZores Pour le coroscanner oui, c'est l'étude SCOT HEART Prospective, compare stratégie "CT first" VS "standard of care" (principalement épreuve d'effort et scinti) dans la suspicion de coronaropathie stable. Le groupe scanner avait moins de MACE à 5 ans ! https://t.co/SwIFzQ7ZFf
All mentions
DANCAVAS Trial: Insights on Cardiovascular Screening Outcomes
The video discusses the FLOW trial of semaglutide, cardiovascular screening findings from the DANCAVAS trial, and noninvasive testing for chest pain. While screening in men aged 65-74 did not significantly reduce…
Impact of Coronary CT Angiography on 5-Year Myocardial Infarction Risk Management
This video discusses a multicenter trial showing that adding coronary CT angiography to standard care reduces 5-year risk of heart attack and death in patients with stable chest pain. It highlights improved outcomes…
Blood Flow Imaging in Cardiology: Coronary CTA Reduces 5-Year Heart Attack Risk
A multicenter trial with 4146 patients found that adding coronary CT angiography to standard care reduced the 5-year risk of death from coronary heart disease or nonfatal myocardial infarction, improving patient…
Evaluating Antiplatelet Therapy Duration in High Bleeding Risk Patients
This week's podcast discusses the importance of dual antiplatelet therapy duration for patients at high bleeding risk after drug-eluting stent placement. The study explores abbreviated therapy effectiveness compared to…
RT @hect2701: #CTAfirst saves lives? Yes, please check this report out…. https://t.co/4kYoaYutPI Do you wait to “embrace” a new approach…
RT @hect2701: #CTAfirst saves lives? Yes, please check this report out…. https://t.co/4kYoaYutPI Do you wait to “embrace” a new approach…
RT @hect2701: #CTAfirst saves lives? Yes, please check this report out…. https://t.co/4kYoaYutPI Do you wait to “embrace” a new approach…
#CTAfirst saves lives? Yes, please check this report out…. https://t.co/4kYoaYutPI Do you wait to “embrace” a new approach until the evidence is created ? Or would you rather embrace your community and create the evidence together? @sbrugaletta @Ortega_Paz @TCTMD @CRT_meeting https://t.co/hXyK17bQDz
L'étude SCOT-HEART 1, publiée en 2018 et 2025, montre cependant que chez les patients SYMPTOMATIQUES, ceux diagnostiqués par coroscanner mourraient moins et avaient moins d'infarctus que les autres. Je l'explique dans la vidéo. https://t.co/SwIFzQ7ZFf
Attended the first presentation of #SCOT_HEART and still enjoy reviewing the elegant paper @NEJM 6 yrs later #David_Newby #CardioTwitter @Steph_Achenbach @AndyJSwift @smrabd @BcsPresident @RCPEdin @SheffieldHosp @ShefUni_ClinMed https://t.co/rLGKeZnCWp
RT @mirvatalasnag: 6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early d…
RT @mirvatalasnag: 6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early d…
RT @mirvatalasnag: 6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early d…
RT @mirvatalasnag: 6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early d…
6.#CACS how it compares to current functional testing & it’s NPV.. CON-beyond calcium: % stenosis, consistency & early detection/prevention #SCOTHEART https://t.co/u25PsmjYUG @NEJM #SCCT2022 https://t.co/ucfoJmARUC
RT @Gurleen_Kaur96: 6/ SCOT HEART study – CCTA had reduction in CHD/MI compared to ETT https://t.co/6D01EuOHLX Risk assessment by CT – not…
RT @Gurleen_Kaur96: 6/ SCOT HEART study – CCTA had reduction in CHD/MI compared to ETT https://t.co/6D01EuOHLX Risk assessment by CT – not…
6/ SCOT HEART study – CCTA had reduction in CHD/MI compared to ETT https://t.co/6D01EuOHLX Risk assessment by CT – not just for statins In future, can guide PCSK9, BP control, antiplatelet, lifestyle changes, amongst others #ASPC2021 https://t.co/hdxyCDQYQi
@Cardiotweets83 @Cardio_ciencias @VazyurVasquez @wikimagen @ecardioimage @iamritu @purviparwani @VLSorrellImages @JGrapsa @jpcostabel @josejgdnews @carlos_sierra @hatemsoliman SCOT Heart https://t.co/pCiYnLi9GM
RT @hect2701: @edurontoFF @omendiz @secardiologia @lamelaspablo @Ortega_Paz @jpcostabel @jgranadacrf @gonzaeperez @Juan_Terre @torresviera…
@edurontoFF @omendiz @secardiologia @lamelaspablo @Ortega_Paz @jpcostabel @jgranadacrf @gonzaeperez @Juan_Terre @torresviera Concuerdo con el hecho que se hará más TAC y menos estudios funcionales. Además el uso de TAC reduce mortalidad a 5 años https://t.co/4kYoaYutPI
@FZores Pour le coroscanner oui, c'est l'étude SCOT HEART Prospective, compare stratégie "CT first" VS "standard of care" (principalement épreuve d'effort et scinti) dans la suspicion de coronaropathie stable. Le groupe scanner avait moins de MACE à 5 ans ! https://t.co/SwIFzQ7ZFf
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction - Cardiology https://t.co/t6Nl43FeBX
... prise en charge. C'est ce qu'a montré l'étude SCOT-HEART, avec un taux de MACE significativement abaissé dans le groupe screené par coroscanner VS tests fonctionnels. https://t.co/SwIFzQ7ZFf
RT @ColinBerryMD: @CoronaryDoc @purviparwani @GreggWStone @Drroxmehran @mmamas1973 @rallamee @RonBlankstein @DavidLBrownMD @DrMarthaGulati…
RT @ColinBerryMD: @CoronaryDoc @purviparwani @GreggWStone @Drroxmehran @mmamas1973 @rallamee @RonBlankstein @DavidLBrownMD @DrMarthaGulati…
RT @ColinBerryMD: @CoronaryDoc @purviparwani @GreggWStone @Drroxmehran @mmamas1973 @rallamee @RonBlankstein @DavidLBrownMD @DrMarthaGulati…
@CoronaryDoc @purviparwani @GreggWStone @Drroxmehran @mmamas1973 @rallamee @RonBlankstein @DavidLBrownMD @DrMarthaGulati @AChoiHeart @ToddVillinesMD @DrRyanPDaly @lesleejshaw @onco_cardiology @MBittencourtMD @ErinMichos Measure coronary outcomes with a coronary intervention = scene set for positive result, but unmeasured outcomes may be equally important. 5yr mortality was no different with CTCA strategy in SCOTHEART https://t.co/PD2Pl3aPGX https://t.co/5Be91kilwZ
Añadir la coronario-TC al proceso clínico del dolor torácico estable, disminuye la ratio de infarto de miocardio y de muerte coronaria a los 5 años. #RadiologíaPensandoEnTi Coronary CT Angiography and 5-Year Risk of Myocardial Infarction | NEJM https://t.co/GTZg6i1Vbk
Though not seen in shorter studies, the 5-year follow-up from the SCOT-HEART trial showed a decrease in deaths from coronary heart disease or non fatal MIs without increase in procedural interventions! https://t.co/F2rW9HQAC9
RT @evandrofilhobr: SCOT-HEART feelings
SCOT-HEART feelings
Coronary CT Angiography and 5-Year Risk of Myocardial Infarction | NEJM https://t.co/KB92m2iJrw
@djc795 @venkmurthy @DhirajGuptaBHRS @AlexNowbar @deb_cohen @BBCNewsnight @bmj_latest @NEJM But you're not suggesting that if the results were presented honestly and transparently, NEJM would have objected? I'm reminded of this paper https://t.co/aoHsqVq9Hs MI was not the primary outcome but made it into the title.
@djc795 @bogdienache @DavidLBrownMD @venkmurthy @MarcDweck @drjohnm @segfaultman @CardiologyCoder @nz_philip @imagingmedsci It’s here: https://t.co/avwEeVkJlL
@djc795 @DavidLBrownMD @venkmurthy @MarcDweck @drjohnm @segfaultman @CardiologyCoder @nz_philip @imagingmedsci Not a prank. Protocol is on NEJM website. https://t.co/NUAhiJgKMl This is on page 109/114 in PDF file. https://t.co/lOFrPb2Kos
@djc795 @venkmurthy @bogdienache @MarcDweck @drjohnm @segfaultman @CardiologyCoder @nz_philip @imagingmedsci And of course @NEJM bought right into it by making the MI result the title of the paper: "Coronary CT Angiography and 5-Year Risk of Myocardial Infarction." Too bad the reviewers are anonymous.
Great article: Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. https://t.co/nrG9lRZ4WJ #ReadByQxMD
Test Not Guess Coronary CT Angiography and 5-Year Risk of Myocardial Infarction | NEJM https://t.co/MOlCg6vvOc
RT @mirvatalasnag: @twj1974 @Ortega_Paz @EuroInterventio @PCRonline @escardio @RaberLorenz #EIJCardioChat Some imagers may disagree CONFI…
@twj1974 @Ortega_Paz @EuroInterventio @PCRonline @escardio @RaberLorenz #EIJCardioChat Some imagers may disagree CONFIRM & SCOT-HEART generated outcome data https://t.co/u25Psm2o38 https://t.co/bXORX9bcfP
安定狭心症、落ち着いているので精査なくそのままフォローとなっていることありますが、時々はCTA(CT冠動脈造影)やはり必要かな。 N Engl J Med. 2018 Sep 6;379(10):924-933 Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
SCOT-HEART study 2018: CTA+standard care = "significantly lower rate of death from coronary heart disease or nonfatal MI at 5 years than standard care alone". Ask us how at #CVSummit this week. Full article @NEJM : https://t.co/Sq1clFbbyb
5) Asking for a CT coronary angiogram may be a good idea if one suspect's coronary disease. https://t.co/N0C1WVCPwC
SCOT-HEART Trial Coronary CT Angiography and 5-Year Risk of Myocardial Infarction https://t.co/EPU8JTSL7e
RT @Heart_SCCT: #SCOTHEART “definitively demonstrated” use of CCTA in addition to standard care to result in an important reduction in coro…
#SCOTHEART “definitively demonstrated” use of CCTA in addition to standard care to result in an important reduction in coronary heart disease death or non-fatal myocardial infarction @journalCCT Drs @Nz_Phil & Newby https://t.co/nQtflfbscJ https://t.co/HSmvVRx2FK